0 0 0
Dieser Online-Shop verwendet Cookies für ein optimales Einkaufserlebnis. Dabei werden beispielsweise die Session-Informationen oder die Spracheinstellung auf Ihrem Rechner gespeichert. Ohne Cookies ist der Funktionsumfang des Online-Shops eingeschränkt. Sind Sie damit nicht einverstanden, klicken Sie bitte hier.
Precision Molecular Pathology of Glioblastoma

Otero, Becker Precision Molecular Pathology of Glioblastoma

Molecular Pathology Library

ISBN: 978-3-030-69169-1

Auflage: 1st Ed.

Erscheinungsdatum: Mai 2021

Einband: Hardcover

Seitenzahl: 266 p.

Illustrationen: 62 ill.

Verlag: Springer

Dieser Artikel ist Teil des Reihenwerks "Molecular Pathology Library"

Lieferzeit ab Ihrer Bestellung: 2-14 Tage je nach Lieferbarkeit und Verlag

Beschreibung

  • Written and edited by experts in the fields of pathology and neuropathology 
  • Includes the integration of molecular and histomorphological features pertinent to glioblastoma classification
  • Includes chapters dedicated to resources for neuropathologists in low and middle income countries

This volume provides a balanced and realistic review of the current state of glioblastoma, ranging from traditional histological review, molecular pathology of glioma, modern radiomics, neurosurgical focus, and integration of treatment plans by neuro-oncologists. The book reviews basic principles such as epidemiology and etiology, and modern 2016 WHO classification of CNS tumors. Chapters cover a general overview of common molecular techniques used in molecular pathology, molecular pathology in a developing country, key drivers of patient outcomes and predictors of response to radiation and/or chemotherapy treatment, and immunohistochemical surrogates for key molecular pathology. It concludes with reviews on radiomics, animal and stem cell models of glioblastoma, and a chapter on the emerging field of Glioblastoma Neuroscience.  

Precision Molecular Pathology of Glioblastoma is intended for pathology residents and fellows interested in glioblastoma, general surgical pathologists who need reviews on how to implement modern glioblastoma classification, as well as neuro-radiologists, oncologists, and radiation oncologists needing a holistic perspective to glioblastoma diagnosis and management.